Store

Sodium Hyaluronate Pharma Grade 150

$75,00 / gram

Minimum 10g.
The volume ordered can be incremented by 10 grams minimum value.

SKU: Product# 4266221

Description

Sodium Hyaluronate Pharma Grade 150 is based on a sodium hyaluronate fermented from Streptococcus zooepidemicus harvested and purified to an extreme degree of purity. The residual levels of endotoxins and proteins allows for use directly in vivo without need for any allergenic tests prior to administration. The product has a molecular weight in the 1400000 – 1800000 g/mol range (calculated from intrinsic viscosity data). Sold per gram, minimum order is 10 grams.

  • Intrinsic Viscosity [m3/kg] : 2.1-2.8
  • Appr. Mw [kDa] : 1200-1900
  • Endotoxins [EU/g]: ≤ 40

Specifications

Generic Name
Storage
Identification - IR Spectrum
Identification - Reaction of sodium
Appearance of solution
Absorbance at 600 nm
pH
Intrinsic viscosity
Nucleic acid (absorbance at 260nm)
Protein
Ethanol
Heavy metals
Chlorides
Iron
Loss on drying
Microbial limits (bioburden)
Bacterial endotoxins
Assay

Quality

NovaMatrix® produces and supplies well-characterized and documented ultrapure, bio-compatible and bio-absorbable biopolymers for use in the pharmaceutical, biotechnology and biomedical industries.

These may include, but not be limited to applications such as drug delivery, tissue engineering, cell encapsulation, and medical devices. For our ultrapure sodium alginates and sodium hyaluronate, we maintain Drug Master Files with the US FDA. NovaMatrix® products are intended to be used in applications which require high and consistent quality provided by our manufacturing,

Quality Control and Quality Assurance. NovaMatrix® manufacture PRONOVA™ sodium alginate in our facilities in Norway. We operate according to GMP guidelines; ICH Q7, ICH Q1, ICH Q2 and ISO standards; ISO 9001:2008 and ISO 13485:2003.

Furthermore NovaMatrix® holds the Manufacturing License for API’s issued by the Norwegian Medicine Agency (NOMA). Our Sodium Hyaluronate ultrapure products are produced using non-animal origin sources by our partner, Kikkoman Biochemifa Company, Japan, under GMP guidelines; the Pharmaceutical and Madical Devices Act, ICH Q7 and ISO standards; ISO 9001:2008 and ISO 14001:2004.

Safety & toxicology

Application examples

Dermal Fillers, Osteoarthritis, Anti-Adhesion, Drug Delivery, Eye surgery, Urology, Tissue Engineering, Replacement of Injured Cartilage.